Recent Finacing
Recent Raise
Beijing Kemei Dongya Biotech produces CLIA-based in vitro diagnostic reagents across 130+ immunoassay, clinical chemistry, infectious disease and cancer‑marker tests, with distribution across 30 Chinese provinces and CE approval.
